| Symbol | BMRA |
|---|---|
| Name | BIOMERICA INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | In Vitro & In Vivo Diagnostic Substances |
| Address | 17571 VON KARMAN AVENUE, IRVINE, CA 92614 |
| Telephone | 9493792875 |
| Fax | — |
| — | |
| Website | https://www.biomerica.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000073290 |
| Description | Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the companys revenue is earned from the Europe market. Additional info from NASDAQ: |
New Form 3 - BIOMERICA INC <b>Filed:</b> 2026-09-10 <b>AccNo:</b> 0001213900-26-098843 <b>Size:</b> 9 KB
Read moreNew Form 3 - BIOMERICA INC <b>Filed:</b> 2026-09-08 <b>AccNo:</b> 0001493152-26-041784 <b>Size:</b> 8 KB
Read moreBiomerica, Inc. - Biomerica Reports Fiscal 2026 Year-End Financial Results
Read moreNew Form 10-K - BIOMERICA INC <b>Filed:</b> 2026-08-31 <b>AccNo:</b> 0001493152-26-040851 <b>Size:</b> 7 MB
Read moreNew Form SCHEDULE 13D - BIOMERICA INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001213900-26-095193 <b>Size:</b> 34 KB
Read moreBiomerica, Inc. - Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
Read more